Global Digital Diabetes Management Market Segmentation, By Product and Services (Devices, Digital Diabetes Management Apps, Data Management Software and Platforms, Services), Type (Wearable Devices, Handheld Devices), Application (Diabetes and Blood Glucose Tracking Apps, Obesity and Diet Management Apps, Data Management Software and Platforms, Services), End User (Home Care Settings, Diabetes Clinics, Academic and Research Institutes, Others) – Industry Trends and Forecast to 2031.
Digital Diabetes Management Market Analysis
Diabetes affects 422 million people worldwide, according to WHO estimates and is directly responsible for at least 1.6 million deaths each year. The healthcare industry has seen a sudden increase in diabetic patients worldwide over the last three decades. Diabetes patients are increasing the strain on global healthcare facilities, which is expected to cost at least USD 490 billion by 2030. Diabetes is a chronic disease that must be properly managed by constantly monitoring blood sugar levels and lifestyle choices. Diabetic patients must live their lives with greater scrutiny than non-diabetic patients.
Digital Diabetes Management Market Size
Global digital diabetes management market size was valued at USD 21.31 billion in 2023 and is projected to reach USD 44.37 billion by 2031, with a CAGR of 9.60% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Digital Diabetes Management Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Abbott (U.S.), PHC Holdings Corporation (Japan), WellDoc, Inc (India), Sanofi (France), Dexcom, Inc (U.S.), DarioHealth Corp. (U.S.), Medtronic (Ireland), B. Braun Melsungen AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Insulet Corporation (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Tidepool (U.S.), Medtronic (Ireland), Tandem Diabetes Care (U.S.), LifeScan (U.S.), AgaMatrix (U.S.), Glooko Inc. (U.S.), DarioHealth (Israel)
|
|
Market Opportunities
|
|
Digital Diabetes Management Market Definition
Digital diabetes management refers to medical solutions used for remote diabetes monitoring, analysis, and management. Diabetes is a metabolic disorder that causes the body's blood sugar levels to rise. The use of software-based applications, platforms, and devices, such as smart glucose metres, insulin pens, sensors, closed-loop systems, and insulin patches, is part of digital diabetes management. These systems are used to manage blood glucose, blood pressure, and cholesterol levels, as well as effectively track and maintain patient records. They also aid in the improvement of healthcare processes, the delay or prevention of diabetes complications, and the reduction of medical costs for patients. As a result, they are widely used in at-home and self-care settings, as well as hospitals, clinics, and research institutes.
Digital Diabetes Management Market Dynamics
Drivers
- Technological advancements will bolster the growth
Emerging technologies in smart insulin pens are projected to drive the global digital diabetes management market during the forecast period. For detecting the insulin level, iSenz adaptor is used for smart insulin pens. It offers the injection angles for diabetic injection site optimization. For insulin pens connected to the internet, there is an adaptor called Easylog. In order to manage chronic illnesses like diabetes, it gives patient the proper dosage and delivers improved comfort. InsulCheck is a cap that fits insulin pens and has a sensor to monitor temperature and consumption. And these are some of the examples of smart insulin pens which accelerate the market growth.
- Integration of monitoring and therapeutic features
Smart insulin pens have many benefits for diabetes management. These pens have extra features that make it easier to keep track of the previous insulin dose. Daily injections of insulin with a syringe and needle are challenging and unpleasant. The improvements in device communication technology, more people are using their smartphones and the internet to track their records and drives the growth of the market.
Opportunities
- Integration of data analytics and artificial intelligence
Big data analytics and artificial intelligence are radically changing the field of digital diabetes management. With new efficient digital diabetes management technologies, the market is expected to grow at an exponential rate, allowing for better diabetes control. The increasing use and growth of bigdata analytics will provide healthcare professionals and patients with access to real-time structured as well as large unstructured data.
Furthermore, AI-powered digital diabetes management devices will aid in providing patients with customised hypoglycemic control solutions. The device was created to provide patients with personalised insights into their glucose level response based on their food intake, insulin dosage, and daily routines. Thus, advent of such novel and booming technologies in the field of digital diabetes management will augment the market growth in the coming years.
Restraints/Challenges
- High cost and lack of awareness will restrain the growth rate
High cost of digital diabetes management and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Also, market growth in developing countries is hampered by a lack of awareness about digital diabetes management and patient data privacy concerns.
This digital diabetes management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital diabetes management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Digital Diabetes Management Market
The COVID-19 pandemic has boosted the growth of the market for digital diabetes management devices. Blood glucose control became critical for patients admitted to hospitals with severe lung infections. The medications used to treat the disease caused a significant change in the blood glucose levels of the patients. Furthermore, the Centers for Disease Control and Prevention stated that people with diabetes who were diagnosed with COVID-19 were admitted to critical care. As a result, the demand for diabetes management devices has skyrocketed.
Digital Diabetes Management Market Scope
The digital diabetes management market is segmented on the basis of product and services, type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Devices
- Smart Glucose Meters
- Continuous Glucose Monitoring (CGM) Systems
- Smart Insulin Pens
- Smart Insulin Pumps/Closed-loop Pumps and Smart Insulin Patches
- Digital Diabetes Management Apps
- Data Management Software and Platforms
- Services
Type
- Wearable Devices
- Handheld Devices
Application
- Diabetes and Blood Glucose Tracking Apps
- Obesity and Diet Management Apps
- Data Management Software and Platforms
- Services
End User
- Home Care Settings
- Diabetes Clinics
- Academic and Research Institutes
- Others
Digital Diabetes Management Market Regional Analysis
The digital diabetes management market is analysed and market size insights and trends are provided by country, product and services, type and end user as referenced above.
The countries covered in the digital diabetes management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the digital diabetes management market because of the presence of well-developed healthcare infrastructure and favourable reimbursement policies in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The digital diabetes management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital diabetes management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital diabetes management market. The data is available for historic period 2010-2020.
Digital Diabetes Management Market Share
The digital diabetes management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital diabetes management market.
Digital Diabetes Management Market Leaders Operating in the Market Are:
- Abbott (U.S.)
- PHC Holdings Corporation (Japan)
- WellDoc, Inc (India)
- Sanofi (France)
- Dexcom, Inc (U.S.)
- DarioHealth Corp. (U.S.)
- Medtronic (Ireland)
- B. Braun Melsungen AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Insulet Corporation (U.S.)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- Tidepool (U.S.)
- Medtronic (Ireland)
- Tandem Diabetes Care (U.S.)
- LifeScan (U.S.)
- AgaMatrix (U.S.)
- Glooko Inc. (U.S.)
- DarioHealth (Israel)
Latest Developments in Digital Diabetes Management Market
- In November 2020, Abbott launched its FreeStyle Libre system in India, expanding its market offerings. The device monitors blood glucose levels in real time and provides a comprehensive overview of an individual's glucose level. As a result, the increasing availability of advanced continuous glucose monitoring devices, as well as the introduction of novel technologies, will drive segment growth during the forecast period.
- In November 2020, Ypsomed and Lilly will collaborate to advance an automated insulin delivery system. Lilly commercialised a new version of insulin pump and CGM system as part of the collaboration, which has aided its business growth.
SKU-